Possible progression of subacute lupus erythematosus--case report

Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2014-04, Vol.118 (2), p.381-386
Hauptverfasser: Brănişteanu, Daciana Elena, Lăbonţu, Andreea, Ciobanu, Delia, Stoleriu, Gabriela, Brănişteanu, D, Oanţă, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 386
container_issue 2
container_start_page 381
container_title Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi
container_volume 118
creator Brănişteanu, Daciana Elena
Lăbonţu, Andreea
Ciobanu, Delia
Stoleriu, Gabriela
Brănişteanu, D
Oanţă, A
description Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551020784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551020784</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-4e33c0b642215ded7998e55841f570428f3ab8fafc2776c0054ad0099a4f805e3</originalsourceid><addsrcrecordid>eNo1j8tqwzAURLVoaUKaXyhadiO4lnUteRlCXxBoF-3ayPJVG7AjV49F_r4uTVfDMIdh5oqtAZQR2iizYtuUjj1Ag1oZxBu2kgi60aDWbPcWfsOR-BzDZ6TFhBMPnqfSW1cy8bHMJXGK5_xFk80hlSSEs4l4pDnEfMuuvR0TbS-6YR-PD-_7Z3F4fXrZ7w5irmSThaK6dtA3SsoKBxp02xpCNKryuCyRxte2N956J7VuHAAqOwC0rVXeAFK9Yfd_vcvQ70Ipd9MxORpHe6JQUlchViBhebygdxe09BMN3RyPk43n7v92_QMI8lOC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551020784</pqid></control><display><type>article</type><title>Possible progression of subacute lupus erythematosus--case report</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</creator><creatorcontrib>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</creatorcontrib><description>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</description><identifier>ISSN: 0048-7848</identifier><identifier>PMID: 25076704</identifier><language>eng</language><publisher>Romania</publisher><subject>Administration, Cutaneous ; Arm - pathology ; Disease Progression ; Drug Therapy, Combination ; Emollients - therapeutic use ; Glucocorticoids - administration &amp; dosage ; Glucocorticoids - therapeutic use ; Humans ; Knee - pathology ; Lip - pathology ; Lupus Erythematosus, Cutaneous - diagnosis ; Lupus Erythematosus, Cutaneous - drug therapy ; Lupus Erythematosus, Cutaneous - pathology ; Male ; Middle Aged ; Mouth Mucosa - pathology ; Nails - pathology ; Skin - pathology ; Treatment Outcome</subject><ispartof>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014-04, Vol.118 (2), p.381-386</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25076704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brănişteanu, Daciana Elena</creatorcontrib><creatorcontrib>Lăbonţu, Andreea</creatorcontrib><creatorcontrib>Ciobanu, Delia</creatorcontrib><creatorcontrib>Stoleriu, Gabriela</creatorcontrib><creatorcontrib>Brănişteanu, D</creatorcontrib><creatorcontrib>Oanţă, A</creatorcontrib><title>Possible progression of subacute lupus erythematosus--case report</title><title>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</title><addtitle>Rev Med Chir Soc Med Nat Iasi</addtitle><description>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</description><subject>Administration, Cutaneous</subject><subject>Arm - pathology</subject><subject>Disease Progression</subject><subject>Drug Therapy, Combination</subject><subject>Emollients - therapeutic use</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Knee - pathology</subject><subject>Lip - pathology</subject><subject>Lupus Erythematosus, Cutaneous - diagnosis</subject><subject>Lupus Erythematosus, Cutaneous - drug therapy</subject><subject>Lupus Erythematosus, Cutaneous - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Mucosa - pathology</subject><subject>Nails - pathology</subject><subject>Skin - pathology</subject><subject>Treatment Outcome</subject><issn>0048-7848</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tqwzAURLVoaUKaXyhadiO4lnUteRlCXxBoF-3ayPJVG7AjV49F_r4uTVfDMIdh5oqtAZQR2iizYtuUjj1Ag1oZxBu2kgi60aDWbPcWfsOR-BzDZ6TFhBMPnqfSW1cy8bHMJXGK5_xFk80hlSSEs4l4pDnEfMuuvR0TbS-6YR-PD-_7Z3F4fXrZ7w5irmSThaK6dtA3SsoKBxp02xpCNKryuCyRxte2N956J7VuHAAqOwC0rVXeAFK9Yfd_vcvQ70Ipd9MxORpHe6JQUlchViBhebygdxe09BMN3RyPk43n7v92_QMI8lOC</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Brănişteanu, Daciana Elena</creator><creator>Lăbonţu, Andreea</creator><creator>Ciobanu, Delia</creator><creator>Stoleriu, Gabriela</creator><creator>Brănişteanu, D</creator><creator>Oanţă, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Possible progression of subacute lupus erythematosus--case report</title><author>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-4e33c0b642215ded7998e55841f570428f3ab8fafc2776c0054ad0099a4f805e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Cutaneous</topic><topic>Arm - pathology</topic><topic>Disease Progression</topic><topic>Drug Therapy, Combination</topic><topic>Emollients - therapeutic use</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Knee - pathology</topic><topic>Lip - pathology</topic><topic>Lupus Erythematosus, Cutaneous - diagnosis</topic><topic>Lupus Erythematosus, Cutaneous - drug therapy</topic><topic>Lupus Erythematosus, Cutaneous - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Mucosa - pathology</topic><topic>Nails - pathology</topic><topic>Skin - pathology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brănişteanu, Daciana Elena</creatorcontrib><creatorcontrib>Lăbonţu, Andreea</creatorcontrib><creatorcontrib>Ciobanu, Delia</creatorcontrib><creatorcontrib>Stoleriu, Gabriela</creatorcontrib><creatorcontrib>Brănişteanu, D</creatorcontrib><creatorcontrib>Oanţă, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brănişteanu, Daciana Elena</au><au>Lăbonţu, Andreea</au><au>Ciobanu, Delia</au><au>Stoleriu, Gabriela</au><au>Brănişteanu, D</au><au>Oanţă, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible progression of subacute lupus erythematosus--case report</atitle><jtitle>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</jtitle><addtitle>Rev Med Chir Soc Med Nat Iasi</addtitle><date>2014-04</date><risdate>2014</risdate><volume>118</volume><issue>2</issue><spage>381</spage><epage>386</epage><pages>381-386</pages><issn>0048-7848</issn><abstract>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</abstract><cop>Romania</cop><pmid>25076704</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0048-7848
ispartof Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014-04, Vol.118 (2), p.381-386
issn 0048-7848
language eng
recordid cdi_proquest_miscellaneous_1551020784
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Administration, Cutaneous
Arm - pathology
Disease Progression
Drug Therapy, Combination
Emollients - therapeutic use
Glucocorticoids - administration & dosage
Glucocorticoids - therapeutic use
Humans
Knee - pathology
Lip - pathology
Lupus Erythematosus, Cutaneous - diagnosis
Lupus Erythematosus, Cutaneous - drug therapy
Lupus Erythematosus, Cutaneous - pathology
Male
Middle Aged
Mouth Mucosa - pathology
Nails - pathology
Skin - pathology
Treatment Outcome
title Possible progression of subacute lupus erythematosus--case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20progression%20of%20subacute%20lupus%20erythematosus--case%20report&rft.jtitle=Revista%20medico-chirurgicala%20a%20Societatii%20de%20Medici%20si%20Naturalisti%20din%20Iasi&rft.au=Br%C4%83ni%C5%9Fteanu,%20Daciana%20Elena&rft.date=2014-04&rft.volume=118&rft.issue=2&rft.spage=381&rft.epage=386&rft.pages=381-386&rft.issn=0048-7848&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1551020784%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551020784&rft_id=info:pmid/25076704&rfr_iscdi=true